Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type
Merck and Co Inc NYSE:MRK NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.97 -1.11% 86.54 88.01 86.09 87.205 9,001,755 00:56:22

Trending: Merck Reports Court Win in Diabetes Patent Lawsuit Against Viatris

22/09/2022 8:42pm

Dow Jones News


Merck (NYSE:MRK)
Historical Stock Chart


From Aug 2022 to Sep 2022

Click Here for more Merck Charts.

1511 ET -- Merck & Co. is one of the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Earlier Thursday, Merck said a West Virginia district court ruled in its favor in a two-patent infringement suit against Viatris Inc. regarding an ingredient in medication to treat type 2 diabetes. Also on Thursday, Merck said it agreed to buy Vence in a deal that would bolster the drugmaker's animal-health portfolio. Dow Jones & Co. owns Factiva. (susan.solan@wsj.com)

 

(END) Dow Jones Newswires

September 22, 2022 15:27 ET (19:27 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Merck Chart

1 Year Merck Chart

1 Month Merck Chart

1 Month Merck Chart
ADVFN Advertorial
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220925 20:40:36